| Literature DB >> 24907395 |
Felicity C Kalinowski1, Rikki A M Brown1, Clarissa Ganda1, Keith M Giles2, Michael R Epis1, Jessica Horsham3, Peter J Leedman4.
Abstract
microRNAs are a family of endogenous, short, non-coding RNAs that play critical roles in regulating gene expression for key cellular processes in normal and abnormal physiology. microRNA-7 is a 23 nucleotide miRNA whose expression is tightly regulated and restricted predominantly to the brain, spleen and pancreas. Reduced levels of miR-7 have been linked to the development of cancer and metastasis. As a tumor suppressor, miR-7 functions to co-ordinately downregulate a number of direct (e.g. the epidermal growth factor receptor) and indirect (e.g. phospho-Akt) growth promoting targets to decrease tumor growth in vitro and in vivo. In addition, miR-7 can increase the sensitivity of treatment-resistant cancer cells to therapeutics and inhibit metastasis. These data suggest that replacement of miR-7 ('miRNA replacement therapy') for specific human cancers could represent a new treatment approach. This article is part of a Directed Issue entitled: The Non-coding RNA Revolution.Entities:
Keywords: Cancer; Epidermal growth factor receptor; Tumor suppressor; microRNA-7
Mesh:
Substances:
Year: 2014 PMID: 24907395 DOI: 10.1016/j.biocel.2014.05.040
Source DB: PubMed Journal: Int J Biochem Cell Biol ISSN: 1357-2725 Impact factor: 5.085